Exoskeleton Partial-Coated Stem Cells for Infarcted Myocardium Restoring

被引:2
作者
He, Huihui [1 ]
Yuan, Yuan [2 ]
Wu, Yunhong [1 ]
Lu, Jingyi [1 ]
Yang, Xiaofu [1 ]
Lu, Kejie [1 ]
Liu, An [3 ]
Cao, Zelin [4 ]
Sun, Miao [1 ]
Yu, Mengfei [1 ]
Wang, Huiming [1 ]
机构
[1] Zhejiang Univ, Zhejiang Prov Clin Res Ctr Oral Dis, Engn Res Ctr Oral Biomat & Devices Zhejiang Prov, Sch Med,Stomatol Hosp,Sch Stomatol,Key Lab Oral Bi, Hangzhou 310000, Peoples R China
[2] Zhejiang Univ, Univ Edinburgh Inst, Key Lab Tissue Engn & Regenerat Med Zhejiang Prov, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Clin Med Coll 1, Wenzhou 325035, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cell partial encapsulation; exoskeletons; inorganic-organic nanobiohybrids; myocardial infarction; stem cells; STIMULI-RESPONSIVE NANOCARRIERS; CARDIAC ENGRAFTMENT; OXIDATIVE STRESS; IN-VIVO; ANGIOGENESIS; REGENERATION; THERAPY; REPAIR; TRANSPLANTATION; MECHANISMS;
D O I
10.1002/adma.202307169
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal-organic frameworks are generated to produce partial-coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell-based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial-coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin alpha 5 beta 1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial-coated BMSCs display enhanced cell retention in infarcted myocardium through non-invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell-exoskeleton interactions and benefits the rational design and manufacture of next-generation nanobiohybrids. Exoskeletons are generated to produce partial-coated bone marrow stem cells (BMSCs) as a novel biologic formulation with dual-sided characteristics. The exoskeleton side promotes cell viability and targeting, whereas the cell side retains the ability of cell adhesion and external secretion. With the synergism of increased survival, retention, and augmented paracrine secretion, the partial-coated BMSCs exhibit promising heart repair effects.image
引用
收藏
页数:14
相关论文
共 124 条
  • [1] Stem cell death and survival in heart regeneration and repair
    Abdelwahid, Eltyeb
    Kalvelyte, Audrone
    Stulpinas, Aurimas
    Teixeira de Carvalho, Katherine Athayde
    Guarita-Souza, Luiz Cesar
    Foldes, Gabor
    [J]. APOPTOSIS, 2016, 21 (03) : 252 - 268
  • [2] Physical, Spatial, and Molecular Aspects of Extracellular Matrix of In Vivo Niches and Artificial Scaffolds Relevant to Stem Cells Research
    Akhmanova, Maria
    Osidak, Egor
    Domogatsky, Sergey
    Rodin, Sergey
    Domogatskaya, Anna
    [J]. STEM CELLS INTERNATIONAL, 2015, 2015
  • [3] Intramyocardial Injection of Recombinant Adeno-Associated Viral Vector Coexpressing PR39/Adrenomedullin Enhances Angiogenesis and Reduces Apoptosis in a Rat Myocardial Infarction Model
    An, Rui
    Xi, Cong
    Xu, Jian
    Liu, Ying
    Zhang, Shumiao
    Wang, Yuemin
    Hao, Yuewen
    Sun, Lijun
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2017, 2017
  • [4] Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
    Askari, AT
    Unzek, S
    Popovic, ZB
    Goldman, CK
    Forudi, F
    Kiedrowski, M
    Rovner, A
    Ellis, SG
    Thomas, JD
    DiCorleto, PE
    Topol, EJ
    Penn, MS
    [J]. LANCET, 2003, 362 (9385) : 697 - 703
  • [5] Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution
    Barbash, IM
    Chouraqui, P
    Baron, J
    Feinberg, MS
    Etzion, S
    Tessone, A
    Miller, L
    Guetta, E
    Zipori, D
    Kedes, LH
    Kloner, RA
    Leor, J
    [J]. CIRCULATION, 2003, 108 (07) : 863 - 868
  • [6] Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size
    Boomsma, Robert A.
    Swaminathan, Paari Dominic
    Geenen, David L.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 (01) : 17 - 28
  • [7] Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor
    Carrion, Bita
    Kong, Yen P.
    Kaigler, Darnell
    Putnam, Andrew J.
    [J]. EXPERIMENTAL CELL RESEARCH, 2013, 319 (19) : 2964 - 2976
  • [8] Case D. A., 2020, AMBER 2020
  • [9] The SDF-1/CXCR4 axis in stem cell preconditioning
    Cencioni, Chiara
    Capogrossi, Maurizio C.
    Napolitano, Monica
    [J]. CARDIOVASCULAR RESEARCH, 2012, 94 (03) : 400 - 407
  • [10] Application of mesenchymal stem cell sheet to treatment of ischemic heart disease
    Chang, Dehua
    Fan, Taibing
    Gao, Shuang
    Jin, Yongqiang
    Zhang, Mingkui
    Ono, Minoru
    [J]. STEM CELL RESEARCH & THERAPY, 2021, 12 (01)